Mimedx (MDXG) Share-based Compensation Growth (1y) (2011 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 7.56% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | -126.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -126.73% |
| Mar 31, 2026 | -147.21% |
| Dec 31, 2025 | -47.52% |
| Sep 30, 2025 | 29.14% |
| Jun 30, 2025 | 16.16% |
| Mar 31, 2025 | -1.80% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | -13.20% |
| Jun 30, 2024 | 0.76% |
| Mar 31, 2024 | 11.17% |
| Dec 31, 2023 | 727.55% |
| Sep 30, 2023 | 84.99% |
| Jun 30, 2023 | -8.31% |
| Mar 31, 2023 | -2.35% |
| Dec 31, 2022 | -82.57% |
| Sep 30, 2022 | -37.76% |
| Jun 30, 2022 | 9.06% |
| Mar 31, 2022 | 23.24% |
| Dec 31, 2021 | -22.13% |
| Sep 30, 2021 | 3.87% |